Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Biometry and Clinical Epidemiology, Charitéplatz 1, Berlin, 10117, Germany.
Technische Universität Berlin, Straße des 17. Juni 135, 10623, Berlin, Germany.
BMC Med Res Methodol. 2024 Jan 19;24(1):15. doi: 10.1186/s12874-024-02150-4.
Sample size calculation is a central aspect in planning of clinical trials. The sample size is calculated based on parameter assumptions, like the treatment effect and the endpoint's variance. A fundamental problem of this approach is that the true distribution parameters are not known before the trial. Hence, sample size calculation always contains a certain degree of uncertainty, leading to the risk of underpowering or oversizing a trial. One way to cope with this uncertainty are adaptive designs. Adaptive designs allow to adjust the sample size during an interim analysis. There is a large number of such recalculation rules to choose from. To guide the choice of a suitable adaptive design with sample size recalculation, previous literature suggests a conditional performance score for studies with a normally distributed endpoint. However, binary endpoints are also frequently applied in clinical trials and the application of the conditional performance score to binary endpoints is not yet investigated.
We extend the theory of the conditional performance score to binary endpoints by suggesting a related one-dimensional score parametrization. We moreover perform a simulation study to evaluate the operational characteristics and to illustrate application.
We find that the score definition can be extended without modification to the case of binary endpoints. We represent the score results by a single distribution parameter, and therefore derive a single effect measure, which contains the difference in proportions [Formula: see text] between the intervention and the control group, as well as the endpoint proportion [Formula: see text] in the control group.
This research extends the theory of the conditional performance score to binary endpoints and demonstrates its application in practice.
样本量计算是临床试验计划的核心方面。样本量是基于参数假设(如治疗效果和终点的方差)计算的。这种方法的一个基本问题是,在试验之前,真实分布参数是未知的。因此,样本量计算总是包含一定程度的不确定性,导致试验的效能不足或过大。应对这种不确定性的一种方法是适应性设计。适应性设计允许在中期分析时调整样本量。有许多这样的重算规则可供选择。为了指导具有样本量重算的适应性设计的选择,先前的文献建议使用正态分布终点的条件性能评分来研究。然而,二进制终点也经常在临床试验中应用,并且尚未研究将条件性能评分应用于二进制终点的情况。
我们通过提出相关的一维评分参数化来扩展二进制终点的条件性能评分理论。此外,我们还进行了一项模拟研究,以评估操作特性并举例说明应用。
我们发现,评分定义可以不经修改就扩展到二进制终点的情况。我们通过一个单一的分布参数来表示评分结果,因此得出了一个单一的效应度量,其中包含干预组和对照组之间的比例差异[公式:见正文],以及对照组中的终点比例[公式:见正文]。
本研究将条件性能评分理论扩展到二进制终点,并展示了其在实践中的应用。